Renee Brant, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 30 Lincoln St, Newton Highlands, MA 02461 Phone: 617-964-6982 Fax: 617-969-7803 |
Dr. Jose A Saporta Jr., MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 53 Beverly Rd, Newton Highlands, MA 02461 Phone: 617-527-6117 |
Ioana Liana Popa, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1163 Walnut St, Office 6, Newton Highlands, MA 02461 Phone: 617-455-7192 |
J P Strang, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 173 Lincoln St, Newton Highlands, MA 02461 Phone: 617-527-1855 |
Dr. Fredric Schiffer, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 30 Lincoln St, Newton Highlands, MA 02461 Phone: 617-969-1188 |
Deborah S Kadish, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4 Hartford St, Newton Highlands, MA 02461 Phone: 617-558-5223 |
Dr. Allen Jay Palmer, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 25 Saxon Rd, Newton Highlands, MA 02461 Phone: 617-965-7077 Fax: 617-965-7077 |
News Archive
Scientists from Dalian Institute of Chemical Physics and Shanghai Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences revealed that UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis.
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells (adult human).
Today's headlines include more analysis of the events that led to a resolution of Virginia's budget impasse and Gov. Terry McAuliffe's hope to expand Medicaid.
Governments should consider stockpiling zanamivir as an anti-influenza agent in their pandemic plans, states a Comment in this week's issue of The Lancet.
› Verified 3 days ago